| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
1 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.0027 |
1 |
| mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0032 |
1 |
| mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
0.0031 |
1 |
| mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
1 |
| mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.003 |
1 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
1 |
| mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |